
LHX · NYSE
The supplied consensus is Buy across 20 analysts, with a mean price target of $387. The data provide no low or high target, so the target spread cannot be measured, and no named analyst is identified as the most or least bullish. No attributable rating or price-target revisions from the past week are supplied, preventing a conclusion about whether estimates moved higher or lower. The substantive disagreement appears to be between the company’s strong operating indicators—second-quarter beats, broad-based segment growth, a raised 2026 outlook and record backlog—and the market’s concerns about geopolitical conditions, macroeconomic pressure and the stock’s sharp post-results decline. The consensus therefore remains positive, but the evidence does not support a more detailed analyst ranking.